Valcreate Investment Life Sciences and Specialty Opportunities Strategy

The strategy involves investing in companies with innovative products and services which give them an edge in the long term growth trajectory. This would be a more sector focused investment with primary focus on the following sectors -pharmaceutical, healthcare, animal health, seeds, agrochemicals and specialty chemicals. It may also include certain other niche businesses which have a technology or product/service edge. Under this investment strategy there shall be no market cap preferences. The strategy will invest minimum 70% of the portfolio investment in these companies. This would categorise as a more aggressive portfolio.

To invest in portfolio of stocks following the buy and hold approach with a reasonable diversification to mitigate the risk.